Winner Medical Acquires 100% Stake in Guilin Latex, Expanding into Medical Latex Market
SHENZHEN, China, July 5, 2022 /PRNewswire/ -- Winner Medical Co. Ltd. (300888.SZ; "Winner Medical" and "the Company"), a leading manufacturer of disposable wound care and surgical products, held an inauguration ceremony for Winner (Guilin) Latex Products Co., Ltd in Guilin, Guangxi Province on June 29, 2022, following its acquisition of a 100% stake in Guilin Zizhu Latex Products Co., Ltd...
EditForce and Mitsubishi Tanabe Pharma Enter into License Agreement
FUKUOKA, Japan, July 5, 2022 /PRNewswire/ -- EditForce, Inc. (Headquarters: Fukuoka, President and CEO: Takashi Ono; hereinafter "EditForce") has entered into a License Agreement (hereinafter "Agreement") with Mitsubishi Tanabe Pharma Corporation (Headquarters: Osaka, Representative Director: Hiroaki Ueno; hereinafter "MTPC") to research, develop and commercialize potential gene therapy products for a specific target disease in the field of CNS...
NHS Scotland awards national laboratory medicine framework to Citadel Health
EDINBURGH, Scotland, July 5, 2022 /PRNewswire/ -- Scotland is on its way to becoming home to the UK's largest connected laboratory medicine network, following the appointment of Citadel Health as the supplier for NHS Scotland's Laboratory Information Management System (LIMS) framework. The new software will connect NHS laboratory medicine labs and hospitals across Scotland. The network has the potential to link...
Endurance RP Limited (SEHK:0575.HK) Operational Update on the PE Prevention Drug Fortacin™ / Senstend™
Phase 3 Study in China is Estimated to Complete in November 2022 HONG KONG, July 5, 2022 /PRNewswire/ -- Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to provide updates on the PE prevention drug - Fortacin™ / Senstend™ (the marketing name of Fortacin™ in China). China Regarding the clinical...
Breakthrough radiology AI provider annalise.ai appoints proven global healthcare leader as CEO, officially launches US team following FDA clearances
Seasoned health technology executive Lakshmi Gudapakkam to become CEO and former HCA Healthcare, Inc. executive Dr Rick Abramson appointed as Chief Medical Officer. New leadership team to drive expansion of world's first comprehensive AI radiology platform globally and entry into the US. CADt FDA approvals for Annalise Enterprise CXR to bring new opportunities for US clinicians. SYDNEY, July 5,...
QunaSys co-hosts industry, government leaders for Pistoia Alliance Global Knowledge-Sharing virtual event
Event focuses on real-world use cases for new technologies, including quantum, poised to improve health and the life sciences TOKYO, July 5, 2022 /PRNewswire/ -- QunaSys, a global leader in the development of innovative quantum algorithms in chemistry and a Pistoia Alliance member company, will co-host the Pistoia Alliance Global Knowledge-Sharing...
ClinChoice Raises $150 mm Series E Round Financing, Further Strengthening its Global Services Capabilities
PHILADELPHIA, July 5, 2022 /PRNewswire/ -- Recently, ClinChoice announced the successful completion of its $150 mm Series E round financing. The investment was led by Legend Capital, and co-invested by Taikang Life Insurance, Sherpa Healthcare Partners and existing shareholders, including Lilly Asia Ventures and Apricot Capital. Proceeds of the financing will be used to fund the Company's continued business expansion and...
WuXi Biologics Extends Capabilities to Include Development and cGMP Manufacturing for Microbial-Derived Products
WuXi Biologics expands its extensive integrated CRDMO services by offering development and cGMP manufacturing for microbial-derived products. HANGZHOU, China, July 5, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG14 facility in Hangzhou has been released for manufacturing microbial-derived products. The facility has been...
Arctic Vision Announces First Patient Enrolled in Phase III Clinical Trial of ARVN003 for Presbyopia
This is the first clinical trial approved in China for presbyopia drugs and Arctic Vision's study marks the first patient enrollment in a Phase III clinical trial for presbyopia drugs in China. ARVN003 is expected to be the first approved drug for presbyopia in China. SHANGHAI, July 4, 2022 /PRNewswire/ -- Arctic Vision, a China-based biotech company focused on innovative...
World’s largest civilian hospital ship in port in Senegal
STOCKHOLM, July 4, 2022 /PRNewswire/ -- On behalf of the charity Mercy Ships, Stena RoRo has been responsible for the construction of the Global Mercy, the world's largest civilian hospital ship. The ship has now been ceremoniously inaugurated in Dakar, Senegal. While the celebrations were still underway, the crew had already begun with the ship's first mission in strengthening African...
